Department of Pain, Ganzhou People's Hospital, No. 17, Hongqi Avenue, Zhanggong District, Ganzhou City, Jiangxi Province, 341000, China.
Department of Anesthesiology, Ganzhou People's Hospital, No. 18, Meiguan Avenue, Zhanggong District, Ganzhou City, 341000, China.
Int J Surg. 2019 Aug;68:92-103. doi: 10.1016/j.ijsu.2019.06.008. Epub 2019 Jun 27.
To compare the efficacy and safety of intra-articular injection and subacromial injection in the treatment of primary frozen shoulder (FS).
We conducted a systematic literature search for all relevant studies on Medline, Embase, Web of Science and Cochrane Central, up to April 2019 with no restrictions to language of publication. The primary outcome was visual analog scale (VAS) score, range of motion (ROM), and Constant shoulder score. The secondary outcome was injection-related adverse effects. Two authors independently assessed the risk of bias using the Cochrane risk-of-bias tool. Data were conducted using STATA version 12.0 (STATA corp., College Station, TX).
Seven randomized controlled trials (RCTs) involving 421 participants were finally included in the present meta-analysis. Our study indicated that intra-articular injection was associated with a statistically significant reduction in the outcome of pain score compared with the subacromial injection. No significant differences were identified between two groups regarding the ROM or post-injection adverse events.
Intra-articular injection of corticosteroid was associated with an improved outcomes for pain relief compared to subacromial injection. There was no significant difference regarding the shoulder function or adverse effects.
比较关节内注射和肩峰下注射治疗原发性冻结肩(FS)的疗效和安全性。
我们对 Medline、Embase、Web of Science 和 Cochrane Central 进行了系统的文献检索,检索时间截至 2019 年 4 月,对发表语言没有限制。主要结局指标是视觉模拟评分(VAS)、关节活动度(ROM)和 Constant 肩部评分。次要结局指标是注射相关不良反应。两名作者使用 Cochrane 偏倚风险工具独立评估了偏倚风险。数据采用 STATA 版本 12.0(STATA corp.,College Station,TX)进行分析。
最终纳入了 7 项随机对照试验(RCT),共 421 名参与者。本研究表明,与肩峰下注射相比,关节内注射在疼痛评分的结局上有统计学意义的降低。两组在 ROM 或注射后不良反应方面无显著差异。
与肩峰下注射相比,皮质类固醇关节内注射可改善疼痛缓解的效果。在肩部功能或不良反应方面没有显著差异。